State of Wyoming’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-39,018
Closed -$86.6K 2034
2025
Q3
$86.6K Buy
+39,018
New +$63.5K 0.01% 1350
2023
Q4
Sell
-41,268
Closed -$68.5K 1763
2023
Q3
$68.5K Buy
+41,268
New +$74.1K 0.01% 1104

Other funds holding PLX

State of Wyoming's PLX Position: Q4 2025 in Review

State of Wyoming sold out of Protalix BioTherapeutics (PLX) in Q4 2025, closing a stake of 39,018 shares — an estimated $86.6K sold.

State of Wyoming first reported a position in PLX in Q3 2023 and held it in 2 quarters. The position peaked at $86.6K in Q3 2025. 83 funds tracked by Wall St. Rank hold PLX as of Q4 2025.

  • State of Wyoming reported no remaining Protalix BioTherapeutics position as of Q4 2025 after selling out during the quarter.
  • State of Wyoming sold 39,018 Protalix BioTherapeutics shares in Q4 2025, an estimated $86.6K.
  • State of Wyoming first reported a position in Protalix BioTherapeutics in Q3 2023 and held it in 2 quarters.
  • State of Wyoming's Protalix BioTherapeutics position peaked at $86.6K in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q4 2025.

Based on State of Wyoming's 13F filing for Q4 2025, filed 11 Feb 2026.